Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-06 4:44 pm Purchase |
2023-06-30 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,363,333 13.600% |
81,406 (+3.57%) |
Filing History |
| 2023-04-19 4:24 pm Purchase |
2023-03-31 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,281,927 17.500% |
78,214 (+3.55%) |
Filing History |
| 2023-02-14 5:01 pm Sale |
2022-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management, LLC | 531,204 7.300% |
-74,530 (-12.30%) |
Filing History |
| 2023-02-14 4:35 pm Purchase |
2023-02-10 | 13D | Fortress Biotech, Inc. FBIO |
KATZ DARYL | 403,532 4.760% |
29,707 (+7.95%) |
Filing History |
| 2023-02-09 11:19 am Sale |
2022-12-30 | 13G | Fortress Biotech, Inc. FBIO |
The Vanguard Group | 340,294 4.700% |
-39,058 (-10.30%) |
Filing History |
| 2023-01-13 4:13 pm Purchase |
2023-01-06 | 13D | Mustang Bio, Inc. MBIO |
Fortress Biotech Inc. FBIO |
1,525,375 20.700% |
1,525,375 (New Position) |
Filing History |
| 2023-01-13 4:13 pm Purchase |
2023-01-05 | 13D | Checkpoint Therapeutics, Inc. CKPT |
Fortress Biotech Inc. FBIO |
2,203,713 19.300% |
2,203,713 (New Position) |
Filing History |
| 2023-01-06 4:31 pm Purchase |
2022-12-31 | 13D | Avenue Therapeutics, Inc. ATXI |
Fortress Biotech Inc. FBIO |
7,710 11.300% |
4,296 (+125.86%) |
Filing History |
| 2022-08-17 4:01 pm Purchase |
2021-11-16 | 13G | Journey Medical Corporation DERM |
Fortress Biotech Inc. FBIO |
10,010,467 56.900% |
10,010,467 (New Position) |
Filing History |
| 2022-02-14 08:13 am Purchase |
2021-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management, LLC | 605,734 9.600% |
27,006 (+4.67%) |
Filing History |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Fortress Biotech, Inc. FBIO |
The Vanguard Group | 379,352 5.710% |
379,352 (New Position) |
Filing History |
| 2021-05-07 5:09 pm Purchase |
2021-04-30 | 13G | Fortress Biotech, Inc. FBIO |
BLACKROCK INC BLK |
320,948 5.000% |
6,330 (+2.01%) |
Filing History |
| 2021-02-16 06:23 am Purchase |
2020-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Nantahala Capital Management, LLC | 578,727 9.300% |
578,727 (New Position) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Fortress Biotech, Inc. FBIO |
Opaleye Management Inc. | 259,167 4.150% |
4,160 (+1.63%) |
Filing History |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Fortress Biotech, Inc. FBIO |
BLACKROCK INC BLK |
314,619 5.000% |
314,619 (New Position) |
Filing History |
| 2020-12-28 5:06 pm Purchase |
2020-12-18 | 13D | Fortress Biotech, Inc. FBIO |
KATZ DARYL | 373,825 5.870% |
56,800 (+17.92%) |
Filing History |